Cart
sales@molnova.com
Ibandronate sodium
CAS No. 138844-81-2
Ibandronate sodium( —— )
Catalog No. M11612 CAS No. 138844-81-2
Ibandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 68 | In Stock |
|
| 50MG | 88 | In Stock |
|
| 100MG | 113 | In Stock |
|
| 200MG | 170 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIbandronate sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionIbandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
-
DescriptionIbandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHAP| FPS
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number138844-81-2
-
Formula Weight341.21
-
Molecular FormulaC9H22NNaO7P2
-
Purity>98% (HPLC)
-
SolubilityFree soluble in Water
-
SMILESO.[Na+].[Na+].CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dunford JE, et al. J Pharmacol Exp Ther. 2001 Feb; 296(2):235-42.
molnova catalog
related products
-
GLP-26
GLP-26 is a novel potent HBV capsid modulator that reduces secreted HBeAg in HepNTCPDL cells transfected with HBV wild type with EC50 of 0.7 uM.
-
HEC72702
HEC72702 is a novel potent, orally active inhibitor of HBV capsid assembly, inhibits HBV-DNA levels in HepG.2.2.15 cells with IC50 of 39 nM.
-
NTCP binder peptide ...
NTCP binder peptide WL4 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV.
